Announcement regarding the profit distribution plan for the first half of 2024.
Announcement of Annual Equity Distribution Implementation in 2023
Announcement on the Progress of Controlling Shareholder of the Company Accepting the Non-Remunerated Transfer of State-Owned Equity and Planning for Actual Controller Change of Important Shareholding Companies
Announcement on the 2023 Profit Distribution Plan
2022 Annual Equity Distribution Implementation Notice
Announcement on the 2022 profit distribution plan
Asset evaluation report of all shareholders' equity value projects of Shanghai Xinxing Pharmaceutical Co., Ltd. involved in the proposed equity transfer of Meikang Jiuzhou Pharmaceutical Co., Ltd.
Announcement on the 2021 profit distribution plan
China Pharmaceutical: Notice on the implementation of the 2020 annual distribution of rights
Chinese Medicine: Simplified Report on Changes in Equity (Aerospace Science and Industry Group)
China Pharmaceutical: Simplified Report on Changes in Equity (General Technology Group))
China Pharmaceuticals: Prompt Announcement on Changes in Shareholders' Equity
China Pharmaceutical: 2019 Annual Equity Distribution Implementation Notice
China Pharmaceutical: Announcement on 2019 Profit Distribution Plan
China Pharmaceuticals: Announcement on the listing and circulation of non-public restricted shares
China Pharmaceutical: 2018 Annual Equity Distribution Implementation Notice
China Pharmaceutical: 2017 Annual Equity Distribution Implementation Notice
China Pharmaceutical: 2016 Annual Equity Distribution Implementation Notice
China Pharmaceuticals: Report on the Issuance of Non-public Offering of A-Shares
China Pharmaceutical: Report of China International Finance Corporation on the issuance process of China Medical and Health Industry Co., Ltd.'s non-public offering of A-shares and the compliance of subscribers
No Data